181 related articles for article (PubMed ID: 35691076)
1. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.
Wu J; Yuan M; Shen J; Chen Y; Zhang R; Chen X; Wang H; Yin Z; Zhang X; Liu S; Sun Q
Phytomedicine; 2022 Aug; 103():154229. PubMed ID: 35691076
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
[TBL] [Abstract][Full Text] [Related]
3. PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression.
Sun Q; Yuan M; Wang H; Zhang X; Zhang R; Wang H; Chen X; Zhu M; Liu S; Wu J
Front Oncol; 2021; 11():767116. PubMed ID: 34926270
[TBL] [Abstract][Full Text] [Related]
4. Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ.
Yuan M; Zou X; Liu S; Xu X; Wang H; Zhu M; Xie X; Wang H; Wu J; Sun Q
Biomed Pharmacother; 2020 Sep; 129():110440. PubMed ID: 32768942
[TBL] [Abstract][Full Text] [Related]
5. The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer.
Wu J; Zhang XX; Zou X; Wang M; Wang HX; Wang YH; Li CY; Zhao LG; Chen M; Pei LX; Liu SL; Sun QM
J Ethnopharmacol; 2019 May; 235():56-64. PubMed ID: 30731181
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
[TBL] [Abstract][Full Text] [Related]
7. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
8. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression.
Zhou S; Lan Y; Li Y; Li Z; Pu J; Wei L
Cell Transplant; 2022; 31():9636897221106998. PubMed ID: 35818293
[TBL] [Abstract][Full Text] [Related]
11. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
[TBL] [Abstract][Full Text] [Related]
13. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
14. Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1.
Chen Y; Liu J; Chen Y; Zhang R; Tao J; Chen X; Wang H; Sun Q; Wu J; Liu S
Front Pharmacol; 2023; 14():1159829. PubMed ID: 37601051
[TBL] [Abstract][Full Text] [Related]
15. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
16. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
17. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
18. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
19. OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels.
Chiu CF; Weng JR; Lee SL; Wu CY; Chu PC; Shan YS; Yang HR; Bai LY
Biochem Pharmacol; 2020 Apr; 174():113811. PubMed ID: 31954719
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation.
Petanidis S; Domvri K; Porpodis K; Anestakis D; Freitag L; Hohenforst-Schmidt W; Tsavlis D; Zarogoulidis K
Biomed Pharmacother; 2020 Feb; 122():109461. PubMed ID: 31918262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
